RecruitingNCT06969924
Real-World Data on the Effects of Cardiac Resynchronization Therapy in Adult Patients With Congenital Heart Disease
Sponsor
Leiden University Medical Center
Enrollment
100 participants
Start Date
Jan 1, 2014
Study Type
OBSERVATIONAL
Conditions
Summary
This study aims to evaluate the real-world effects of cardiac resynchronization therapy (CRT) in adult patients with congenital heart disease (ACHD). Specifically, it seeks to determine whether CRT improves clinical outcomes in this unique patient population and to identify factors associated with a favorable response to therapy.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- ACHD patients who underwent CRT implantation
Exclusion Criteria2
- Less than 18 years old on the moment of CRT implantation
- Patient objection to the use of retrospective data
Interventions
DEVICECardiac resynchronization therapy
Cardiac resynchronization therapy pacemaker or defibrillator with a transvenous or epicardial systemic ventricle lead
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06969924
Related Trials
Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders
NCT074771971 location
Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry
NCT0693208111 locations
Efficacy Of Sodium Glucose Transporter Inhibitor (SGLT2I) In Adult Patients With Congenital Heart Disease
NCT062600593 locations